Hikma Pharmaceuticals PLC HIK shares shed 3.16% to £19.02 Friday, on what proved to be an all-around rough trading session ...

Shares of Hikma Pharmaceuticals PLC HIK dropped 1.95% to £19.15 Tuesday, on what proved to be an all-around favorable trading ...

The FDA approved generic versions of Vyvanse from 11 drugmakers, including U.S.-based drugmakers Mallinckrodt and Viatris, UK-based Hikma Pharmaceuticals, and Indian drugmaker Sun Pharmaceutical ...

Semnur Pharmaceuticals, which is working on a non-opioid prospect for sciatica, has agreed to merge with special purpose acquisition company Denali Capital Acquisition Corp. in a deal worth $2.5 ...

On the downside, Hikma Pharmaceuticals slipped by 0.6%, reversing earlier gains that followed an upgrade to 'buy' from 'hold' by Berenberg. Rightmove dropped 5.03%, retreating after Monday's surge.

Barclays cuts Prudential price target to 1,250 (1,380) pence - 'overweight' Barclays reinitiates Barratt Developments with 'overweight' - price target 641 pence Barclays raises HGCapital Trust to ...

Hikma is offering clindamycin in 5% dextrose injection, in 300mg/50ml, 600mg/50ml and 900mg/50ml doses. The product is available in a vial. Clindamycin in 5% dextrose injection is indicated for ...

The workers of Square Pharmaceutical have blocked the Dhaka-Tangail highway with 21-point demands including salary increase, job stabilization, and two-day weekend. The workers of Square ...

New Delhi: To maintain dominance in the global pharmaceutical market and bridge the gap between established and emerging players, Union Minister Jitin Prasada has urged the country’s ...

In this article, we are going to take a look at where Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stands against the other medical AI companies. Generally, when you hear the term "artificial ...